PROVIREX Genome Editing Therapies GmbH

PROVIREX Genome Editing Therapies GmbH is a privately-held biotech company developing first-in-class advanced therapy medicinal products (ATMPs). PROVIREX’s technology is based on error-free genome editing for eradication of life-threatening persistent virus infection.

PROVIREX Genome Editing Therapies GmbH

Luruper Hauptstr. 1
22547 Hamburg

https://www.provirex.de

Category

Biotechnology / Pharma

Sub Category

drug discovery / development / production / retail, analytics & reagents

Zurück